CoreFirst Bank & Trust’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.6K | Buy |
+200
| New | +$17.6K | 0.01% | 270 |
|
|
2025
Q1 | – | Sell |
-200
| Closed | -$17.3K | – | 292 |
|
|
2024
Q4 | $17.3K | Sell |
200
-11,275
| -98% | -$973K | 0.01% | 272 |
|
|
2024
Q3 | $1.09M | Buy |
11,475
+1,215
| +12% | +$115K | 0.63% | 39 |
|
|
2024
Q2 | $939K | Buy |
10,260
+1,500
| +17% | +$137K | 0.63% | 40 |
|
|
2024
Q1 | $795K | Buy |
8,760
+10
| +0.1% | +$907 | 0.5% | 47 |
|
|
2023
Q4 | $712K | Buy |
8,750
+7,800
| +821% | +$635K | 0.47% | 50 |
|
|
2023
Q3 | $75.9K | Buy |
+950
| New | +$75.9K | 0.05% | 193 |
|